Back to results
US 2015/0031623 A1Published application
Thrombopoietin receptor ligands for neuroprotection
AssigneeMCW Research Foundation, Inc.
InventorJohn E. Baker
Life of this patent
Estimating the term…
Abstract
The present invention provides therapeutic modalities for the treatment of an ischemic event (e.g., stroke) that creates or embodies a risk of neurological damage in CNS sites by administration of a thrombopoietin receptor ligand.
Claims10
A method comprising steps of:
- administering to a subject who is suffering from or has recently suffered a an ischemic event that creates or embodies a risk of neurological damage in CNS sites, a composition comprising a thrombopoietin receptor ligand, which composition is formulated and contains an amount of thrombopoietin receptor ligand sufficient to achieve delivery of the thrombopoietin receptor ligand to the CNS.
Dependencies are inferred from the claim text.